ADMA Biologics, Inc. ADMA

$ADMA ImmunoRank, The Alliance’s anti-COVID-19 Hyperimmune Globulin EUA and a blowout 1Q revenue report in May are all potential catalysts. This is a good time to buy.

$ADMA Despite COVID related headwinds, ADMA was able to achieve a 44% increase in revenue in 2020. I think 2021 will be a blowout year.

To all you babies crying because your money did not double in two weeks

Go away. You are incredibly annoying

$ADMA Just added 500 more @ 1.97
Waiting on positive news from Covid Alliance.

$ADMA Just added 2,100 on the dip.

$ADMA Sometimes it takes a day for good news to filter through to investors.

$ADMA https://www.google.com/amp/s/finance.yahoo.com/amphtml/news/adma-biologics-presents-breaking-poster-130000226.html

$ADMA https://www.globenewswire.com/news-release/2021/02/22/2179535/0/en/ADMA-Biologics-to-Participate-in-Raymond-James-Institutional-Investor-Conference.html

$ADMA I should have increased my position yesterday when it dipped to $2.48. We will be in 3’s and 4’s soon.

$ADMA While the trial registry page for the ongoing Phase III ITAC notes trial completion in July, a trial investigator said results should be available soon, likely in 1Q.
https://www.clinicaltrialsarena.com/comment/nihs-hivig-trial-in-hospitalised-covid-19-patients-close-to-meeting-recruitment-target-outpatient-study-planned-for-next-few-months-sources-say/